Atv 20 pill
Pro Research Analysisby 
Searched over 200M research papers
Efficacy of Atorvastatin 20 mg in Type 2 Diabetes Patients
Comparative Efficacy with Ezetimibe/Simvastatin
A study evaluated the efficacy of switching from atorvastatin (ATV) 10 mg to either ezetimibe/simvastatin (EZE/SIMVA) 10/20 mg, EZE/SIMVA 10/40 mg, or doubling the dose of ATV from 10 to 20 mg in patients with type 2 diabetes (T2D). The results indicated that increasing the dose of ATV to 20 mg was a viable option for managing cholesterol levels in these patients, providing a comparable alternative to the EZE/SIMVA combinations.
Impact on Chronic Periodontitis
Atorvastatin 20 mg has also been studied for its effects on chronic periodontitis. In a controlled double-blind study, subjects with chronic periodontitis who received ATV 20 mg daily for three months showed significant improvements in periodontal disease conditions. These improvements included reductions in cholesterol levels, low-density lipoprotein levels, dental mobility, and the distance from the crestal alveolar bone to the cemento-enamel junction, suggesting that ATV might have beneficial effects on bone alveolar loss and tooth mobility in subjects with periodontal disease.
Comparison with Rosuvastatin/Amlodipine Polypill
A multicenter, randomized study compared the efficacy and safety of a rosuvastatin (RSV)/amlodipine (AML) polypill with an atorvastatin (ATV)/AML polypill in patients with hypertension and dyslipidemia. The study found that while both treatments were safe, the RSV/AML polypill was more effective in reducing LDL-C levels compared to the ATV/AML polypill. Specifically, the RSV 10 mg/AML 5 mg and RSV 20 mg/AML 5 mg combinations showed greater reductions in LDL-C levels than the ATV 20 mg/AML 5 mg combination.
Interaction with QiShenYiQi Pills
Research on the interaction between atorvastatin and QiShenYiQi pills (QSYQ), a Chinese patent medicine, revealed that QSYQ increases the bioavailability of orally administered ATV. This effect is achieved by inhibiting the expression of multidrug resistance-associated protein 2 (Mrp2) in the ileum. The study highlighted the importance of monitoring potential drug-drug interactions when ATV is co-prescribed with QSYQ, as the increased bioavailability could impact the drug's efficacy and safety profile.
Conclusion
Atorvastatin 20 mg is effective in managing cholesterol levels in patients with type 2 diabetes and shows promise in improving periodontal disease conditions. However, it may be less effective than rosuvastatin/amlodipine combinations in reducing LDL-C levels in patients with hypertension and dyslipidemia. Additionally, clinicians should be aware of potential interactions with QiShenYiQi pills, which can increase the bioavailability of atorvastatin.
Sources and full results
Most relevant research papers on this topic